Patrick Machado

Mr Machado has served as a member of our board since December 2019. Mr Machado has over two decades of experience growing biopharmaceutical organizations from development through commercialization. He has extensive operational experience, having led finance, business development, and legal functions at multiple companies. Mr Machado co-founded and served as CFO and CBO at Medivation until his retirement in 2014 and served as a member of Medivation’s Board of Directors from 2014 until its acquisition for approximately $14 billion by Pfizer in 2016. During his tenure at Medivation, Mr Machado helped lead the company through substantial growth and challenges, providing strong leadership during the clinical development and successful commercial launch of Xtandi® in prostate cancer.

Prior to Medivation, Mr Machado worked at ProDuct Health, where he held positions as CFO, Senior Vice President of Business Development and General Counsel; Mr Machado was also responsible for working with national health plans in the US to expand access to patients in need of ductal lavage. Earlier in his career, Mr Machado served as chief legal counsel to the Chiron Technologies business unit at Chiron Corporation and led the transaction teams for all substantial Chiron Technologies collaborations. Prior to joining Chiron, Mr Machado worked for Morrison & Foerster LLP, a leading international law firm, and for the Massachusetts Supreme Judicial Court.

Mr Machado received his JD degree from Harvard Law School and holds both a BS degree in Economics and a BA degree in German from Santa Clara University in California.